Monitoring asparaginase activity in middle-income countries-Reference-Cited by-同舟云学术

Monitoring asparaginase activity in middle-income countries

Published:2018-09 Issue:9 Volume:19 Page:1149-1150
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cecconello Daiane Keller,Werlang Isabel Cristina Ribas,Alegretti Ana Paula,Hahn Monique Cabral,de Magalhães Mariana Rodrigues,Battistel Ana Paula,Zenatti Priscila Pini,Yunes Jose Andres,Cabreira-Cagliari Caroline,Rechenmacher Ciliana,Goldani Marcelo Zubaran,Daudt Liane Esteves,Michalowski Mariana Bohns

Publisher

Elsevier BV

Subject

Oncology

Reference6 articles.

1. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: findings from the CONCORD-2 study;Tai;Cancer,2017

2. Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: Final results of the EORTC-CLG randomized phase III trial 58951;Mondelaers;Haematologica,2017

3. Use of L-asparaginase in childhood ALL;Muller;Crit Rev Oncol Hematol,1998

4. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations;Boos;Eur J Cancer,1996

5. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum;Lanvers;Anal Biochem,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences;Pharmaceutics;2024-08-28

2. Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries;Leukemia;2024-05-18

3. Mutations in asparaginase II from E. coli and implications for inactivation and PEGylation;Biophysical Chemistry;2023-08

4. The international scandal of defective asparaginase: A blight on children with cancer;Pediatric Blood & Cancer;2023-05-23

5. A scoping review to compare and contrast quality assurance aspects of l-asparaginase biosimilars;International Journal of Pharmaceutics;2023-02